ArticleClinical and translational medicine2025

Revealing the heterogeneity of treatment resistance in less-defined subtype diffuse large B cell lymphoma patients by integrating programmed cell death patterns and liquid biopsy.

Wei Hua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.